Protective actions of progesterone in the cardiovascular system: Potential role of membrane progesterone receptors (mPRs) in mediating rapid effects

Steroids

Volumn 78, Issue 6, 2013, Pages 583-588

  Thomas, Peter ^a   Pang, Yefei ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cardiovascular; Membrane progesterone receptors; Nongenomic; Nuclear progesterone receptors; Progesterone; Protective

Indexed keywords

CALCIUM; CYCLIC AMP; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGESTERONE; PROGESTERONE RECEPTOR;

BLOOD VESSEL TONE; CALCIUM TRANSPORT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL TYPE; CONFERENCE PAPER; DATA ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; MATERNAL HYPERTENSION; NONHUMAN; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYNTHESIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; HUMANS; MYOCYTES, SMOOTH MUSCLE; PROGESTERONE; RECEPTORS, PROGESTERONE; VASOCONSTRICTION;

ANIMALIA;

EID: 84876687912     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.01.003     Document Type: Conference Paper

References (83)

1. J.M. Orshal, and R.A. Khalil Gender, sex hormones, and vascular tone Am J Physiol Regul Integr Comp Physiol 286 2 2004 R233 R249
2. J.F. Reckelhoff Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations Hypertension 45 2 2005 170 174
3. J.W. Levenson, P.J. Skerrett, and J.M. Gaziano Reducing the global burden of cardiovascular disease: the role of risk factors Prev Cardiol 5 2002 188 199
4. P. Forte, B.J. Kneale, E. Milne, P.J. Chowienczyk, A. Johnston, and N. Benjamin Evidence for a difference in nitric oxide biosynthesis between healthy women and men Hypertension 32 4 1998 730 734
5. N. Winberg, A. Høegholm, H.R. Christensen, L.E. Bang, K.L. Mikkelsen, and P.E. Nielsen 24-h Ambulatory blood pressure in 352 normal danish subjects, related to age and gender Am J Hypertens 8 1995 978 986
6. I. MacGillivray, G.A. Rose, and B. Rowe Blood pressure survey in pregnancy Clin Sci 37 1969 395 407
7. M. Wilson, A.A. Morganti, I. Zervoudakis, R.L. Letcher, B.M. Romney, and P. Von Oeyon Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy Am J Med 68 1980 97 104
8. G.M. Rosano, P.M. Sarrel, P.A. Poole-Wilson, and P. Collins Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease Lancet 342 8864 1993 133 136
9. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 5728 2005 1583 1587
10. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system New Engl J Med 340 1999 1801 1811
11. C.C. Liu, T.B. Kuo, and C.C. Yang Effects of estrogen on gender related autonomic differences in humans Am J Physiol Heart Circ Physiol 285 2003 H2188 H2193
12. M. Perusquia, E. Navarrete, L. Gonzalez, and C.M. Villalon The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery Life Sci 81 2007 993 1022
13. V. Jazbutyte, P.A. Arias-Loza, K. Hu, J. Widder, V. Govindaraj, and C. von Poser-Klein Ligand-dependent activation of ERbeta lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats Cardiovasc Res 77 4 2008 774 781
14. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) Research Group JAMA 280 1998 605 613
15. R.K. Dubey, B. Imthurn, L.C. Zacharia, and E.K. Jackson Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here? Hypertension 44 6 2004 789 795
16. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, and M. Hlatky HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERSII) JAMA 288 1 2002 49 57
17. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's health initiative randomized controlled trial JAMA 288 3 2002 321 333
18. D.A. Grimes, and R.A. Lobo Perspectives on the women's health initiative trial of hormone replacement therapy Obstet Gynecol 100 6 2002 1344 1353
19. R.L. Ross, M.R. Serock, and R.A. Khalil Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease Curr Cardiol Rev 4 2008 309 322
20. A.O. Mueck, and H. Seeger Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women Maturitas 49 2004 189 203
21. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, and N.L. Lasser Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
22. L.M. Brandin, H. Gustafsson, B. Ghanoum, I. Milsom, and K. Manhem Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women Blood Pressure 19 2010 156 163
23. M.R. Adams, J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, and M.S. Wolfe Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone Arteriosclerosis 10 1990 1051 1057
24. G.M. Rosano, C.M. Webb, S. Chierchia, G.L. Morgani, M. Gabraele, and P.M. Sarrel Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in post menopausal women J Am Coll Cardiol 36 2000 2154 2159
25. T. Simoncini, P. Mannella, L. Fornari, A. Caruso, M.Y. Willis, and S. Garibaldi Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells Endocrinology 145 2004 5745 5756
26. T. Chataigneau, M. Zerr, M. Chataigneau, F. Hudlett, C. Hirn, and F. Pernot Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats Menopause 11 3 2004 255 263
27. A. Nath, and R. Sitruk-Ware Different cardiovascular effects of progestins according to structure and activity Climateric 12 Suppl. 1 2009 96 101
28. T. Simoncini, X.-D. Fu, A. Caruso, S. Garibaldi, C. Baldacci, and M.S. Giretti Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors Human Reprod 22 8 2007 2325 2334
29. E. Boschitsch, S. Mayerhofer, and D. Magometschnigg Hypertension in women: the role of progesterone and aldosterone Climacteric 13 2010 307 313
30. A.O. Mueck, and H. Seeger Progestogens and target tissues: vascular systems Maturitas 62 2009 356 361
31. R.L. Landau, D.M. Bergenstal, K. Lugibihl, and M.E. Kascht The metabolic effects of progesterone in man J Clin Endocrinol Metab 15 1955 1194 1215
32. D.-Y. Lee, J.-Y. Kim, J.-H. Kim, D.-S. Choi, D.-K. Kim, and K.K. Koh Effects of hormone therapy on ambulatory blood pressure in postmenopausal Korean women Climacteric 14 2011 92 99
33. M. Barbagallo, L.J. Dominguez, G. Licata, J. Shan, L. Bing, and E. Karpinski Vascular effects of progesterone: role of cellular calcium regulation Hypertension 37 1 2001 142 147
34. P.B. Rylance, M. Brincat, K. Lafferty, J.C. De Trafford, S. Brincat, and V. Parson Natural progesterone and antihypertensive action Br Med J 290 1985 13 14
35. H.A. Omar, R. Ramirez, and M. Gibson Properties of a progesterone-induced relaxation in human placental arteries and veins J Clin Endocrinol Metab 80 1995 370 373
36. J.G. Regensteiner, W.R. Hiatt, R.L. Byny, C.K. Pickett, W.D. Woodard, and L. Grindlay Moore Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women J Clin Pharmacol 31 1991 543 548
37. E.D. Szmuilowicz, G.K. Adler, V. Ricchiuti, P.N. Hopkins, and E.W. Seely Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women J Clin Endocrinol Metab 92 2007 4738 4741
38. M.B. Sammour, M.N. El-Makhzangy, M.M. Fawzy, and A. Shindler Progesterone therapy in pregnancy-induced hypertension: therapeutic value and hormone profile Clin Exp Hypertens 1 1982 455 478
39. P. Kristiansson, and J.X. Wang Reproductive hormones and blood pressure during pregnancy Human Reprod 16 2001 13 17
40. E.A. Karpanou, G.P. Vyssoulis, D.G. Georgoudi, M.G. Toutouza, and P.K. Toutouzas Ambulatory blood pressure changes in the menstrual cycle of hypertensive women. Significance of plasma renin activity values Am J Hypertens 6 1993 654 659
41. M. Pecins-Thompson, and M. Keller-Wood Effects of progesterone on blood pressure, plasma volume, and responses to hypotension Am J Physiol 272 1997 R377 R385
42. D.M. Roesch, and M. Keller-Wood Progesterone rapidly reduces arterial pressure in ewes Am J Physiol 271 1997 H386 H391
43. T. Nakamura, K. Matsui, M. Ito, T. Yoshimura, N. Kawasaky, S. Fujisaky, and H. Okamura Effects of pregnancy and hormone treatments on pressor response to angiotensin II in conscious rats Am J Obstet Gynecol 159 1988 989 995
44. K. Novak, and S. Kauffman Effect of pregnancy, estradiol, and progesterone on pressor responsiveness to angiotensin II Am J Physiol 261 1991 R1164 R1170
45. G. Nickenig, K. Strehlow, S. Wassmann, A.T. Bäumer, K. Albory, and H. Sauer Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells Circulation 102 15 2000 1828 1833
46. R.K. Hermsmeyer, R.G. Mishra, D. Pavcnik, B. Uchida, M.K. Axthelm, and F.Z. Stanczyk Prevention of coronary hyperactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone Arterioscler thromb Vasc Biol 24 2004 955 961
47. V.V. Dhote, and R. Balaraman Gender specific effects of progesterone on myocardial ischemia/reperfusion injury in rats Life Sci 81 2007 188 197
48. D.O. Ruehlmann, and G.E. Mann Rapid non-genomic vasodilator actions of estrogens and sex steroids Curr Medic Chem 7 2000 533 541
49. R.W.Y. Chow, D.J. Handelsman, and M.K.C. Ng Minireview: rapid actions of sex steroids in the endothelium Endocrinology 151 6 2010 2411 2422
50. R.D. Minshall, D. Pavcnik, D.L. Browne, and K. Hermsmeyer Nongenomic vasodilator action of progesterone on primate coronary arteries J Appl Physiol 92 2 2002 701 708
51. M.E. Mendelsohn Genomic and nongenomic effects of estrogen in the vasculature Am J Cardiol 90 1A 2002 3F 6F
52. M.P. Haynes, D. Sinha, K.S. Russell, K.S. Russell, M. Collinge, and D. Fulton Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells Circ Res 87 8 2000 677 682
53. K.L. Chambliss, and P.W. Shaul Estrogen modulation of endothelial nitric oxide synthase Endocr Rev 23 2002 665 686
54. Z. Chen, I.S. Yuhanna, Z. Galcheva-Gargova, R.H. Karas, M.E. Mendelsohn, and P.W. Shaul Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen J Clin Invest 103 1999 401 406
55. R.J. Ramírez, M. Gibson, J. Kalenic, S. Einzig, and H.A. Omar In vitro vascular relaxation to progesterone and its metabolites in human umbilical and placental blood vessels J Maternal-Fetal Invest 8 2 1998 61 65
56. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
57. Y. Zhang, S.P. Janssens, K. Wingler, H.H. Haraold, W. Schmidt, and A.L. Moens Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy Am J Physiol Heart Circ Physiol 301 2011 H634 H646
58. J. Selles, N. Polini, C. Alvarez, and V. Massheimer Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation Life Sci 69 2001 815 827
59. (2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone J Pharmacol Exp Ther 291 1 1999 44 52
60. V. Boonyaratnakonkit, M.P. Scott, V. Ribon, L. Sherman, S.M. Anderson, and J.L. Maller Progesterone receptor contains a proline rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinase Mol Cell 8 2 2001 269 280
61. C.R. Hagan, E.J. Faivre, and C.A. Lange Scaffolding actions of membrane-associated progesterone receptors Steroids 74 2009 568 572
62. H. Tatsumi, J. Kitawaki, K. Tanaka, T. Hosoda, and H. Honjo Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins Maturitas 42 2002 287 294
63. B. Toth, G. Saadat, A. Geller, C. Scholz, S. Schulze, and K. Friese Human umbilical vascular endothelial cells express estrogen receptor beta (ERβ) and progesterone receptor A (PR-A), but not ERα and PR-B Histochem Cell Biol 130 2008 399 405
64. Y. Nakamura, T. Suzuki, T. Inoue, C. Tazawa, K. Ono, and T. Moriya Progesterone receptor subtypes in vascular smooth muscle cells of human aorta Endocr J 52 2 2005 245 252
65. S.P. Hsu, and W.S. Lee Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells Mol Endocrinol 25 2011 421 432
66. B.H. Welter, E.L. Hansen, K.J. Saner, Y. Wei, and T.M. Price Membrane-bound progesterone receptor expression in human aortic endothelial cells J Histochem Cytochem 51 2003 1049 1055
67. Y. Pang, and P. Thomas Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and C-terminal truncated isoforms of the nuclear progesterone receptor Steroids 76 2011 921 928
68. G. Madsen, D.A. Macintyre, S. Mesiano, and R. Smith Progesterone receptor or cytoskeletal protein? Reprod Sci 14 3 2007 217 222
69. A. Samalecos, and B. Gellersen Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C PR-M, or other truncated PR isoforms Endocrinology 149 11 2008 5872 5887
70. P. Thomas, Y. Pang, J. Dong, P. Groenen, J. Kelder, and J. de Vlieg Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor α subtypes and their evolutionary origin Endocrinology 148 2 2007 705 718
71. Y.T. Tang, T. Hu, M. Arterburn, B. Boyle, J.M. Bright, and P.C. Emtage PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif J Mol Evol 61 2005 372 380
72. J.L. Smith, B.R. Kupchak, I. Garitaonandia, L.K. Haong, A.S. Maina, L.M. Regall, and L.K. Lyons Heterologous expression of human mPRα, mPRβ and mPRγ in yeast confirms their ability to function as membrane progesterone receptors Steroids 73 2008 1160 1173
73. Y. Zhu, C.D. Rice, Y. Pang, M. Pace, and P. Thomas Cloning expression and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes Proc Natl Acad Sci USA 100 2003 2231 2236
74. Y. Zhu, J. Bond, and P. Thomas Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor Proc Natl Acad Sci USA 100 2003 2237 2242
75. E. Karteris, S. Zervou, Y. Pang, J. Dong, E.D. Hillhouse, and H.S. Randeva Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term Mol Endocrinol 20 7 2006 1519 1534
76. P. Thomas Characteristics of membrane progestin receptor alpha (mPR alpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions Front Neuroendocrinol 29 2 2008 292 312
77. P. Thomas Rapid steroid hormone actions initiated at the cell surface and the receptors that mediate them with an emphasis on recent progress in fish models Gen Comp Endocrinol 175 2012 367 383
78. G.E. Dressing, R. Alyea, Y. Pang, and P. Thomas Membrane progesterone receptors (mPRs) mediate anti morbidity in breast cancer cells and are expressed in human breast tumors Horn Cancer 3 2012 101 112
79. B -independent effects of progesterone on GnRH release Endocrinology 150 2009 3833 3844
80. C. Dosiou, A.E. Hamilton, Y. Pang, M.T. Overgaard, S. Tulac, and J. Dong Expression of membrane progesterone receptors (mPRs) on human T lymphocytes and Jurkat cells and activation of G proteins by progesterone J Endocrinol 196 2008 67 71
81. J. Kelder, R. Azevedo, Y. Pang, J. de Vlieg, J. Dong, and P. Thomas Comparison between steroid binding to membrane progesterone receptor α (mPRα) and to nuclear progesterone receptor: Correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPR alpha-specific agonists Steroids 75 4-5 2010 314 322
82. T. Simoncini, R. Apa, F.M. Reis, F. Miceli, M. Stomati, and L. Driul Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor J Clin Endocrinol Metab 84 1999 2802 2806
83. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J Clin Invest 52 11 1973 2745 2756